INSM
Insmed Inc
NASDAQ: INSM · HEALTHCARE · BIOTECHNOLOGY
$135.03
+0.07% today
Updated 2026-04-29
Market cap
$29.15B
P/E ratio
—
P/S ratio
48.06x
EPS (TTM)
$-6.42
Dividend yield
—
52W range
$64 – $213
Volume
2.3M
Insmed Inc (INSM) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
1 of 8
Last 8 quarters
Avg EPS surprise
-28.3%
Last 4 quarters
Revenue YoY growth
+152.6%
Most recent quarter
EPS YoY growth
-16.7%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+8.4%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
+17.5%
2025-10-29
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-19 | $-1.54 | -31.6% | $151.11 | $164.91 | +9.1% |
| 2025-10-29 | $-1.75 | -32.6% | $165.29 | $194.22 | +17.5% |
| 2025-08-07 | $-1.70 | -30.8% | $111.26 | $109.55 | -1.5% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-1.17 | $-1.54 | -31.6% | $263.84M | +152.6% |
| 2025-09-30 | $-1.32 | $-1.75 | -32.6% | $142.34M | +52.4% |
| 2025-06-30 | $-1.30 | $-1.70 | -30.8% | $107.42M | +18.9% |
| 2025-03-31 | $-1.20 | $-1.42 | -18.3% | $92.82M | +22.9% |
| 2024-12-31 | $-1.23 | $-1.32 | -7.3% | $104.44M | +24.8% |
| 2024-09-30 | $-1.22 | $-1.27 | -4.1% | $93.42M | +18.2% |
| 2024-06-30 | $-1.27 | $-1.94 | -52.8% | $90.34M | +17.0% |
| 2024-03-31 | $-1.23 | $-1.06 | +13.8% | $75.50M | — |
| 2023-12-31 | $-1.15 | $-1.28 | -11.3% | $83.69M | — |
| 2023-09-30 | $-1.13 | $-1.11 | +1.8% | $79.07M | — |
| 2023-06-30 | $-1.13 | $-1.78 | -57.5% | $77.23M | — |
Analyst EPS and revenue estimates for upcoming years
| Period | EPS estimate | Revenue estimate | Revenue growth | Analysts | Confidence |
|---|---|---|---|---|---|
| 2026 (E) | $-2.93 | $1.7B | +177.0% | 24 | high |
| 2027 (E) | $0.48 | $2.8B | +66.5% | 24 | high |
| 2028 (E) | $2.85 | $4.2B | +50.0% | 24 | medium |
| 2029 (E) | $5.20 | $5.6B | +33.3% | 24 | medium |
| 2030 (E) | $7.80 | $7.1B | +26.8% | 24 | medium |
Frequently asked questions
Has Insmed Inc beaten earnings estimates?
Insmed Inc has beaten Wall Street EPS estimates in 1 of its last 8 quarterly reports, with an average EPS surprise of -28.3% over the last 4 quarters.
How does INSM stock react to earnings?
INSM stock has moved an average of +8.4% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.
What is Insmed Inc's revenue growth rate?
Insmed Inc reported year-over-year revenue growth of +152.6% in its most recent quarter, with EPS growing -16.7% year-over-year.
What is the expected EPS for INSM in 2026?
Analysts expect Insmed Inc to report EPS of $-2.93 for fiscal year 2026, on revenue of $1.7B, based on estimates from 24 analysts.